NEULANDLABBSENEULAND LAB LTD.· Pharmaceuticals & BiotechnologyHighNegative
Announced Mon, 17 Aug, 2026 · 14:03 IST

Malabar India Fund sells 2.72 lakh shares, stake drops to 5.06%

Fii Holding DeclinedOwnership Changes View source PDFExplain this filing

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.4%Reaction day
₹23330.00
prior close
₹23635.00
announcement price
In-mkt
timing
Nifty Smallcap 250market+0.2%+1.2% vs market
Pharmaceuticals peers, median of 167sector-0.4%+1.8% vs sector

On the reaction day the stock moved 1.2 pts more than Nifty Smallcap 250 and 1.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-0.1
15m
+0.0
30m
-0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.4+0.2+1.2-0.4+1.8
Next day
+0.3+0.4-0.1-0.0+0.3
2d
-0.1-0.3+0.1-0.8+0.6
3d
+1.0+0.3+0.7-0.5+1.5
4d
-0.3+0.7-1.0-0.8+0.5
5d
-1.8+0.5-2.3-0.5-1.3
1w
+1.2+1.0+0.2-0.8+2.0
15d
-1.6+1.1-2.8+1.4-3.0
1m
-3.1-1.5-1.7+0.6-3.7
2m
-17.5-4.6-12.9-4.1-13.4
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

FII Malabar India Fund Limited sold 2,72,634 equity shares of Neuland Laboratories in the open market between 10 August 2024 and 14 August 2026. Its holding fell from 7.18% (9,21,371 shares) to 5.06% (6,48,737 shares), a 2.12% reduction. Malabar is not part of the promoter group.

Likely market impact

Continued FII selling pressure; reduces significant foreign institutional stake but no promoter change.